Roger G. Spragg

16.6k total citations · 3 hit papers
103 papers, 12.6k citations indexed

About

Roger G. Spragg is a scholar working on Pulmonary and Respiratory Medicine, Endocrine and Autonomic Systems and Molecular Biology. According to data from OpenAlex, Roger G. Spragg has authored 103 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 19 papers in Endocrine and Autonomic Systems and 14 papers in Molecular Biology. Recurrent topics in Roger G. Spragg's work include Respiratory Support and Mechanisms (47 papers), Neonatal Respiratory Health Research (47 papers) and Neuroscience of respiration and sleep (19 papers). Roger G. Spragg is often cited by papers focused on Respiratory Support and Mechanisms (47 papers), Neonatal Respiratory Health Research (47 papers) and Neuroscience of respiration and sleep (19 papers). Roger G. Spragg collaborates with scholars based in United States, Canada and Germany. Roger G. Spragg's co-authors include Leonard D. Hudson, Gordon R. Bernard, Antonio Artigas, Maurice Lamy, Jean Carlet, Kenneth L. Brigham, K. J. Falke, Alison Morris, Charles G. Cochrane and Ingrid U. Schraufstätter and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Roger G. Spragg

102 papers receiving 12.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The American-European Consensus Conference On Ards. Definitions, Mechanisms, Relevant Outcomes, And Clinical Trial Coordination

1994 5.1k citations Gordon R. Bernard, Antonio Artigas et al. American Journal of Respiratory and Critical Care Medicine profile →
Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide.

1988 533 citations Roger G. Spragg, Charles G. Cochrane et al. profile →
Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination

1994 519 citations Gordon R. Bernard, Antonio Artigas et al. Intensive Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger G. Spragg United States	41	7.8k	2.6k	2.4k	2.3k	1.6k	103	12.6k
Kenneth L. Brigham United States	54	9.6k 1.2×	3.5k 1.3×	2.3k 1.0×	2.3k 1.0×	2.5k 1.5×	225	17.6k
Rolf D. Hubmayr United States	60	6.6k 0.9×	1.8k 0.7×	2.4k 1.0×	2.6k 1.2×	705 0.4×	191	10.5k
K. J. Falke Germany	38	8.7k 1.1×	2.8k 1.0×	3.1k 1.3×	2.6k 1.2×	475 0.3×	122	12.7k
Jean‐François Pittet United States	58	4.8k 0.6×	2.0k 0.8×	2.8k 1.2×	3.3k 1.4×	3.6k 2.2×	238	14.1k
Timothy W. Evans United Kingdom	55	4.1k 0.5×	1.7k 0.6×	1.0k 0.4×	1.3k 0.6×	1.7k 1.1×	221	10.2k
Patrícia R. M. Rocco Brazil	57	7.0k 0.9×	1.1k 0.4×	1.3k 0.5×	1.6k 0.7×	2.1k 1.3×	491	12.1k
Jesús Villar Spain	46	5.0k 0.6×	2.0k 0.8×	1.7k 0.7×	2.4k 1.1×	1.1k 0.7×	172	7.6k
Polly E. Parsons United States	40	3.7k 0.5×	2.2k 0.8×	974 0.4×	1.4k 0.6×	731 0.4×	77	6.4k
Ivor S. Douglas United States	58	3.3k 0.4×	2.8k 1.1×	1.3k 0.5×	1.9k 0.8×	1.6k 1.0×	194	11.8k
Norman C. Staub United States	48	4.7k 0.6×	621 0.2×	983 0.4×	759 0.3×	859 0.5×	169	7.7k

Countries citing papers authored by Roger G. Spragg

Since Specialization

Citations

This map shows the geographic impact of Roger G. Spragg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger G. Spragg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger G. Spragg more than expected).

Fields of papers citing papers by Roger G. Spragg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger G. Spragg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger G. Spragg. The network helps show where Roger G. Spragg may publish in the future.

Co-authorship network of co-authors of Roger G. Spragg

This figure shows the co-authorship network connecting the top 25 collaborators of Roger G. Spragg. A scholar is included among the top collaborators of Roger G. Spragg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger G. Spragg. Roger G. Spragg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spragg, Roger G., Gordon R. Bernard, William Checkley, et al.. (2010). Beyond Mortality: Future Clinical Research in Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 181(10). 1121–1127. 216 indexed citations

Spragg, Roger G., Friedemann Taut, James F. Lewis, et al.. (2010). Recombinant Surfactant Protein C–based Surfactant for Patients with Severe Direct Lung Injury. American Journal of Respiratory and Critical Care Medicine. 183(8). 1055–1061. 88 indexed citations

Spragg, Roger G., et al.. (2010). An informatics strategy to assure enrollment criteria compliance in studies of the critically ill. Contemporary Clinical Trials. 31(6). 530–535. 2 indexed citations

Taut, Friedemann, Gerd Rippin, Peter Schenk, et al.. (2008). A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement Therapy. CHEST Journal. 134(4). 724–732. 68 indexed citations

Spragg, Roger G., James F. Lewis, W Wurst, et al.. (2003). Treatment of Acute Respiratory Distress Syndrome with Recombinant Surfactant Protein C Surfactant. American Journal of Respiratory and Critical Care Medicine. 167(11). 1562–1566. 127 indexed citations

Spragg, Roger G. & James F. Lewis. (2001). Pathology of the Surfactant System of the Mature Lung. American Journal of Respiratory and Critical Care Medicine. 163(1). 280–282. 22 indexed citations

McCaig, Lynda, et al.. (1999). Dosing and Delivery of a Recombinant Surfactant in Lung-injured Adult Sheep. American Journal of Respiratory and Critical Care Medicine. 159(3). 741–747. 34 indexed citations

Artigas, Antonio, Gordon R. Bernard, Jean Carlet, et al.. (1998). The American–European Consensus Conference on ARDS, Part 2: Ventilatory, Pharmacologic, Supportive Therapy, Study Design Strategies, and Issues Related to Recovery and Remodeling. American Journal of Respiratory and Critical Care Medicine. 157(4). 1332–1347. 352 indexed citations

Spragg, Roger G.. (1998). Surfactant Therapy in Acute Respiratory Distress Syndrome. Neonatology. 74(Suppl. 1). 15–20. 12 indexed citations

10.

Artigas, Antonio, Gordon R. Bernard, Jean Carlet, et al.. (1998). The American-European consensus conference on ARDS, Part 2. Intensive Care Medicine. 24(4). 378–398. 145 indexed citations

11.

Steinberg, K P, Roger G. Spragg, James E. Gadek, et al.. (1997). Bovine Surfactant Therapy for Patients With Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 155(4). 1309–1315. 288 indexed citations

12.

Spragg, Roger G. & R. M. Smith. (1997). Pathology of the Surfactant System of the Mature Lung. American Journal of Respiratory and Critical Care Medicine. 155(2). 756–760. 20 indexed citations

13.

Hopkins, Susan R., R. B. Schoene, William R. Henderson, et al.. (1997). Intense Exercise Impairs the Integrity of the Pulmonary Blood-Gas Barrier in Elite Athletes. American Journal of Respiratory and Critical Care Medicine. 155(3). 1090–1094. 185 indexed citations

14.

Ahuja, Arvind, et al.. (1996). Inhibition of the Human Neutrophil Respiratory Burst by Native and Synthetic Surfactant. American Journal of Respiratory Cell and Molecular Biology. 14(5). 496–503. 45 indexed citations

15.

Pappert, D., et al.. (1996). Effect of N-nitroso-N-methylurethane on gas exchange, lung compliance, and surfactant function of rabbits. Intensive Care Medicine. 22(4). 345–352. 5 indexed citations

16.

Gilliard, Nicolas, et al.. (1991). Radiolabeling of the hydrophobic components of lung surfactant with 3-(trifluoromethyl)-3-(m-[125I]iodophenyl)diazirine. Analytical Biochemistry. 193(2). 310–315. 1 indexed citations

17.

Spragg, Roger G.. (1991). DNA Strand Break Formation Following Exposure of Bovine Pulmonary Artery and Aortic Endothelial Cells to Reactive Oxygen Products. American Journal of Respiratory Cell and Molecular Biology. 4(1). 4–10. 60 indexed citations

18.

Moser, Kenneth Μ., Robert M. Smith, Roger G. Spragg, & Gennaro M. Tisi. (1988). Intravenous administration of alpha-1-proteinase inhibitor in patients of PiZ and PiM phenotype. The American Journal of Medicine. 84. 70–74. 4 indexed citations

19.

Smith, Robert M. & Roger G. Spragg. (1988). Production and administration to dogs of aerosols of alpha-1-proteinase inhibitor. The American Journal of Medicine. 84. 48–51. 4 indexed citations

20.

Smith, Robert M., et al.. (1987). Pulmonary Penetration of Alpha ₁ -Proteinase Inhibitor Administered Parenterally to Dogs. American Review of Respiratory Disease. 136(6). 1391–1396. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact